Cargando…

Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study

In this study, in estrogen receptor positive (ER+) early stage breast cancer patients who were considered candidates for 70-gene signature (70-GS, “MammaPrint”) use, we compared molecular subtyping (MS) based on the previously validated 80-gene signature (80-GS, “BluePrint”) versus surrogate patholo...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Steenhoven, Julia E.C., Kuijer, Anne, van Diest, Paul J., van Gorp, Joost M., Straver, Marieke, Elias, Sjoerd G., Wesseling, Jelle, Rutgers, Emiel, Timmer-Bonte, Johanna N.H., Nieboer, Peter, Smilde, Tineke J., Imholz, Alex, Blanken, Charlotte F.J.M., Siesling, Sabine, van Dalen, Thijs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977201/ https://www.ncbi.nlm.nih.gov/pubmed/29772837 http://dx.doi.org/10.3390/genes9050261

Ejemplares similares

Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early‐stage luminal breast cancer
por: van Steenhoven, Julia E C, et al.
Publicado: (2020)

Patients’ perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict
por: van Steenhoven, Julia E. C., et al.
Publicado: (2020)

The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
por: van Steenhoven, J. E. C., et al.
Publicado: (2019)

Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer Patients
por: van Steenhoven, Julia E. C., et al.
Publicado: (2020)

Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline E. F., et al.
Publicado: (2023)

Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de‐escalating approach
por: van Steenhoven, Julia E. C., et al.
Publicado: (2022)

ASO Author Reflections: The Changing Role of Gene Expression Profiling in ER+/HER2− Breast Cancer
por: van Steenhoven, Julia E. C., et al.
Publicado: (2019)

ASO Author Reflections: Effect Sizes of Whole Breast Radiotherapy and Systemic Therapies on Regional Recurrence Incidence in Breast Cancer Patients
por: van Steenhoven, Julia E. C., et al.
Publicado: (2020)

ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline, et al.
Publicado: (2023)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

Follow-up care by patient's own general practitioner after contact with out-of-hours care. A descriptive study
por: van Uden, Caro JT, et al.
Publicado: (2005)

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ
por: Elshof, Lotte E., et al.
Publicado: (2018)

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study
por: Elshof, Lotte E., et al.
Publicado: (2017)

Perspectives and Attitudes of Dutch Healthcare Professionals Regarding the Integration of Complementary Medicine in Oncology
por: Schouten, Aniek E.M., et al.
Publicado: (2023)

Practical behavioural solutions to COVID-19: Changing the role of behavioural science in crises
por: Tanis, Charlotte C., et al.
Publicado: (2022)

A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples
por: Zwart, Wilbert, et al.
Publicado: (2013)

Incongruence in number–luminance congruency effects
por: Gebuis, Titia, et al.
Publicado: (2010)

The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands
por: Filipe, M. D., et al.
Publicado: (2021)

Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?
por: Patuleia, Susana I. S., et al.
Publicado: (2022)

Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases
por: Jiwa, Laura S, et al.
Publicado: (2014)

The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients
por: van Dooijeweert, C., et al.
Publicado: (2021)

Frozen section analysis of sentinel lymph nodes in patients with breast cancer does not impair the probability to detect lymph node metastases
por: Madsen, Eva V. E., et al.
Publicado: (2011)

Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
por: van Ramshorst, Mette S., et al.
Publicado: (2017)

Workshop on Future Physics at HERA, working group on Light and Heavy Nuclei at HERA
por: van der Steenhoven, G
Publicado: (1996)

95-96 Workshop on Future Physics at HERA : Working Group on Light and Heavy Nuclei at HERA
por: van der Steenhoven, G
Publicado: (1996)

Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands
por: Deukeren, Désirée van, et al.
Publicado: (2022)

Seronegative autoimmune encephalitis: exploring the unknown
por: van Steenhoven, Robin W, et al.
Publicado: (2022)

Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial
por: Straver, Marieke E., et al.
Publicado: (2010)

Price dynamics of red meat types in South Africa for the period 2013 to 2017
por: Van Rensburg, E. Janse, et al.
Publicado: (2020)

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature
por: Knauer, M, et al.
Publicado: (2010)

Towards an open and effective dialogue on complementary medicine in oncology: protocol of patient participatory study ‘COMMON’
por: Mentink, Marit, et al.
Publicado: (2021)

Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer
por: van Uden, D. J. P., et al.
Publicado: (2019)

General practitioners' satisfaction with and attitudes to out-of-hours services
por: van Uden, Caro JT, et al.
Publicado: (2005)

Out-of-hours primary care. Implications of organisation on costs
por: van Uden, Caro JT, et al.
Publicado: (2006)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia
por: Liu, Qiuyu, et al.
Publicado: (2023)

Effects of oncological care pathways in primary and secondary care on patient, professional and health systems outcomes: a systematic review and meta-analysis
por: van Hoeve, Jolanda C., et al.
Publicado: (2020)

Dyadic coping and its association with emotional functioning in couples confronted with advanced cancer: Results of the multicenter observational eQuiPe study
por: van Roij, Janneke, et al.
Publicado: (2022)

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
por: van Uden, Dominique J. P., et al.
Publicado: (2019)

The Impact on Post-surgical Treatment of Sentinel Lymph Node Biopsy of Internal Mammary Lymph Nodes in Patients with Breast Cancer
por: Madsen, EVE, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_6e6ah73a7srpdvutl5dm8tlrrs